Quinapril . hydrochloride



LKT-Q8134-M100	100 mg	67.00 USD

LKT-Q8134-M500	500 mg	200.00 USD

LKT-Q8134-G001	1 g	320.00 USD

A firmly estblished and well tolerated angiotensin-coverting enzyme inhibitor. It attenuates the myocardial infarction induced rise in cardiac cytokine expression. Clinical trials show that quinapril prevents restenosis after coronary stenting in patients with angiotensin-coverting enzyme D allele.

PRODUCT PROPERTIES
Formula:		C₂₅H₃₀N₂O₅ .HCl
MW:		474.99
CAS:		82586-55-8
MI:		13: 8139

Formula:

TECHNICAL DOCUMENTS Print as PDF	RELATED PRODUCTS No related products available
PRODUCT SUPPORT Technical Service Bulk Quantity Quote Customer Service	CATALOG SECTION Angiotensin Converting Enzyme [ACE]... Angiotensin Converting Enzyme [ACE]... Angiotensin Converting Enzyme [ACE]... Angiotensin Converting Enzyme [ACE]... Angiotensin Converting Enzyme [ACE]...

Product Literature References

Effects of quinapril on myocardial function, ventricular remodeling and cardiac cytokine expression in congestive heart failure in the rat: G.C. We, et al.; Cardiovasc.Drugs Ther. 16, 29 (2002), Abstract;

Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale: J.W. Warnica, et al.; Can. J. Cardiol. 18, 1191 (2002), Abstract;

Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders: C.R. Culy and B. Jarvis; Drugs 62, 339 (2002), Abstract;

Quinapril . hydrochloride

TECHNICAL DOCUMENTS

RELATED PRODUCTS

PRODUCT SUPPORT

CATALOG SECTION

Product Literature References